“A Guide to Home-Based COVID Treatment” by the Association of American Physicians and Surgeons includes life-saving best practices for early treatment in an easy-to-understand document for doctors and patients.
“Early treatment should have been part of the equation. I’m not against all those other things. Contagion control is important. Washing our hands. Things like that. They’re all important. Do we need vaccination programs? Absolutely. Do we need early treatment programs? Absolutely. So we have basically put the cart before the horse. The tail is wagging the dog. Early treatment should be a mainstay for everything.”
Borody’s ivermectin triple therapy prophylactic is the perfect solution. It reduces transmission immediately, regardless of the variant, by preventing the virus from entering a person’s cells. It also shortens time spent in quarantine and reduces transmission to close contacts. Early treatment dramatically reduces hospitalisation and mortality and would rapidly end the Sydney wave, as similar therapies did in Mexico and India. It would also put an end to any need for masks and lockdowns.
Dr. Vladimir Zelenko talks with author John Leake about treating his patients for Covid-19 and then sharing his insight with the White House. In spite of (or because of) President Trump’s initial embrace of Dr. Zelenko’s treatment protocol, government agencies such as the NIH and FDA first dismissed it, and then prevented public access to its key ingredient, hydroxychloroquine. This deliberate suppression of a life saving medication led to the preventable deaths of hundreds of thousands of Americans.
The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.
Dr. Risch gives a succinct history of the politics of hydroxychloroquine and other useful existing medicines in the USA, which has had global effect, as many countries look to the USA for guidance. Corruption and manipulation from behind the scenes around the world are brought to the surface for scrutiny.
In absolute honesty, I don’t think vaccines are even necessary. Why are they not necessary? Well that’s because there are at least four or five safe and effective medicines and their presence has been suppressed and hidden from the public, so they’re not really necessary.
“We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients,” the authors of the study noted.
In a new study, Smith and three other medical experts prove what he and this show have been telling you for more than a year that hydroxychloroquine can save lives. Smith’s landmark study followed 255 COVID patients who required intubation during the first two months of the pandemic, and it found that increased doses of coadministered, hydroxychloroquine and azithromycin were associated with a greater than 100% increase in survival.
Over 10,000 patients,a fatality rate more than 97% LOWER than France’s – an exceptional case for early treatment with a drug regimen including HCQ & AZM.
Most Covid studies have not considered days of therapy, cumulative dose, or weight-adjusted dosing. We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients. By using causal analysis and considering of weight-adjusted cumulative dose, we prove the combined therapy, >3 g HCQ and > 1g AZM greatly increases survival in Covid patients on IMV and that HCQ cumulative dose > 80 mg/kg works substantially better. These data do not yet apply to hospitalized patients not on IMV. Since those with higher doses of HCQ had higher doses of AZM, we cannot solely attribute the causal effect to HCQ/AZM combination therapy. However, it is likely AZM does contribute significantly to this increase in survival rate. Since higher dose HCQ/AZM therapy improves survival by nearly 200% in this population, the safety data are moot. However, given the data presented here, the studies reporting HCQ’s effect of QTc intervals need to be re-evaluated.
Significant QT prolongation was not observed during the follow‐up period compared with the baseline values in the present study. No ventricular arrhythmias, second and third‐degree heart blocks, or severe pauses were recorded during the treatment period.
From an ingenious intuition of the founder, Mauro Rango, an Italian living in the Mauritius Islands. There, the Coronavirus was quickly eradicated in the beginning, with drugs that we have known for decades, such as Azithromycin, Hydroxychloroquine or Cortisone, while in Italy people died like flies. How was it possible that in Africa, where health care is not as advanced as in Italy, such marvellous results were achieved, while in Italy the spread of the disease could not be contained?
Antiviral therapy is only of interest during the early and intermediate viral phase when the virus is present and replicates, and is of no use during the late inflammatory phase (cytokine storm). Most therapeutic trials, unfortunately, have been carried out in hospitalized patients, which is to say probably often too late, because the patients are in the early inflammatory phase.
“Dozens of studies being reproduced in several continents show that early treatment within the first five days of observable symptoms, reduces hospitalization in high-risk patients by 84%.
Source: Communities Digital News Author: Rick Johnson LOS ANGELES, CA: As the COVID-19 pandemic explodes in the New York region and across California, the Malaria
•TNR4 is a multidrug therapy (Ivermectin, Azithromycin, Montelukast and ASA) for COVID-19 cases.
•TNR4 increased the likelihood of recovery 3.4 times in ambulatory COVID-19 cases.
•The multidrug therapy TNR4 reduced the risk of hospitalization by 75%.
•The multidrug therapy TNR4 reduced the risk of death by 81%.
No cases of sudden death were observed. From publication, we have treated 3,119 patients with HCQ-AZ for at least three days.
Figure 3 reported random forest for 10 studies comparing HCQ+AZM. Use of the combination HCQ+AZM was associated with 25% lower mortality risk
Professor Raoult had very quickly sent a “warning letter” to the newspaper about this study which seemed to him incomplete and including too much bias.
This unprecedented violation of the sanctity of the doctor-patient relationship, denying Australians access to this drug, must end.
This means that zinc, low dose HCQ, and azithromycin and may prevent a large number of hospitalizations and probably deaths during the SARS-CoV-2 pandemic.
We found a higher survival rate in patients treated with hydroxychloroquine and with macrolides in our study.
This study of critically ill patients with laboratory-confirmed COVID-19 admitted to ICUs in Mexico demonstrated that age and CRP levels upon ICU admission were associated with in-hospital mortality
This petition must be signed so as those responsible for the murder of countless lives can be brought to justice.
Our results can assure that hydroxychloroquine used for COVID-19 patients is safe, highly tolerable, and with minimum side effects.
If the ABC were doing their job, they’d be investigating the greatest scandal of our time – but they are infected with TDS, so they are not interested in the facts or the truth.
Dr Peter McCullough explains how important early outpatient treatment is and presents guidelines for such treatment.
HCQ has greater efficacy if given earlier in the course of the disease. Several negative studies have been withdrawn due to methodological improprieties.
Brian Tyson, a doctor in Southern California has successfully treated over 1,700 patients with the drug hydroxychloroquine.
If these proffesionals all insist the evidence is overwhelming that this protocol is amazingly effective in correct, early use treatment of COVID-infected patients.
So why is it that mainstream media will not push this type of information? The easy answer is MONEY! Hydroxychloroquine stands in the way of trillions of dollars.
In our study, we found hydroxychloroquine wasn’t associated with significant arrhythmia clearly relating to hydroxychloroquine so it seemed the drug was very, very safe
In the first phase of the pandemic, 81% of deaths were in elderly homes. 50% of those deaths due to COVID-19 in nursing homes were avoidable with HCQ.
HCQ, combined with zinc, is a very effective treatment for COVID-19, especially if administered very soon after infection.
Therefore, Hydroxychloroquine is considered as the first‐line of COVID-19 treatment.
Hydroxychloroquine + azithromycin had a significant effect on COVID-19 infected patients length of stay in the hospital.
Source: The Lancet Summary Background Hydroxychloroquine is one of several agents being evaluated in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
In this trial, no deaths occurred related to hydroxychloroquine, and serious side effects were rare.
“Alternative opinions were ignored or ridiculed. We have not seen open debates in the media, where different views could be expressed.”
